Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis receives EU approval for first-line use of Zykadia in ALK-positive advanced NSCLC

cphi-onlineJuly 03, 2017

Tag: Novartis , NSCLC

PharmaSources Customer Service